Mivacurium chloride
Mivacurium chloride: 1 brand, 2 generics; first approved Jan 22, 1992; generic available.
Generic available: 2 ANDA applications approved.
Brand (NDA) products
- MIVACRONRLDABBVIENDA 02009819925 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 2MG BASE/ML (EQ 2MG BASE/ML) SOLUTION INTRAVENOUS Discontinued - EQ 0.5MG BASE/ML INJECTABLE INJECTION Discontinued - EQ 50MG BASE/100ML INJECTABLE INJECTION Discontinued - EQ 10MG BASE/5ML (EQ 2MG BASE/ML) SOLUTION INTRAVENOUS Discontinued - EQ 20MG BASE/10ML (EQ 2MG BASE/ML) SOLUTION INTRAVENOUS Discontinued -
Generic (ANDA) products (2)
- MIVACURIUM CHLORIDEWOODWARDANDA 20970820212 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 10MG BASE/5ML (EQ 2MG BASE/ML) SOLUTION INTRAVENOUS Discontinued - EQ 20MG BASE/10ML (EQ 2MG BASE/ML) SOLUTION INTRAVENOUS Discontinued - - MIVACURIUM CHLORIDERISINGANDA 0785622009
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 2MG BASE/ML INJECTABLE INJECTION Discontinued -
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Approval history
Approvals span 1992–2021 across 3 FDA applications.
Mivacurium chloride: frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
Assyro Intelligence
Ask anything about Mivacurium chloride
Cited answers from FDA, EMA, Health Canada, PubMed and ClinicalTrials.gov, in seconds. Free, no sign-up.
Evaluating for a team? Book a demo